根据ESI于2022年9月发布的数据，我校高被引论文（Highly Cited Papers）254篇，热点论文（Hot Papers）7篇，见附件：2022年9月南方医科大学高被引论文及热点论文简表。详情如下。
从学科角度看，在254篇高被引论文中，临床医学最多（117篇），占比46.06%，分子生物学与遗传学29篇 (11.42%)第二、生物学与生物化学21篇（8.27%）紧跟其后。
|
序号 |
高被引论文 Research Field |
202209 |
202207 |
||
|
论文数 |
占比 |
论文数 |
占比 |
||
|
1 |
CLINICAL MEDICINE |
117 |
46.06% |
107 |
46.52% |
|
2 |
MOLECULAR BIOLOGY & GENETICS |
29 |
11.42% |
24 |
10.43% |
|
3 |
BIOLOGY & BIOCHEMISTRY |
21 |
8.27% |
19 |
8.26% |
|
4 |
PHARMACOLOGY & TOXICOLOGY |
18 |
7.09% |
18 |
7.83% |
|
5 |
MATERIALS SCIENCE |
14 |
5.51% |
13 |
5.65% |
|
6 |
NEUROSCIENCE & BEHAVIOR |
9 |
3.54% |
7 |
3.04% |
|
7 |
ENGINEERING |
5 |
1.97% |
5 |
2.17% |
|
8 |
MICROBIOLOGY |
6 |
2.36% |
7 |
3.04% |
|
9 |
CHEMISTRY |
6 |
2.36% |
5 |
2.17% |
|
10 |
PHYSICS |
2 |
0.79% |
2 |
0.87% |
|
11 |
PSYCHIATRY/PSYCHOLOGY |
9 |
3.54% |
8 |
3.48% |
|
12 |
IMMUNOLOGY |
3 |
1.18% |
3 |
1.30% |
|
13 |
SOCIAL SCIENCES, GENERAL |
5 |
1.97% |
4 |
1.74% |
|
14 |
COMPUTER SCIENCE |
3 |
1.18% |
3 |
1.30% |
|
15 |
GEOSCIENCES |
1 |
0.39% |
1 |
0.43% |
|
16 |
AGRICULTURAL SCIENCES |
2 |
0.79% |
1 |
0.43% |
|
17 |
MULTIDISCIPLINARY |
2 |
0.79% |
1 |
0.43% |
|
18 |
ENVIRONMENT/ECOLOGY |
2 |
0.79% |
2 |
0.87% |
|
19 |
合计 |
254 |
100.00% |
230 |
100.00% |
|
序号 |
2022年9月我校7篇热点论文 标题 |
来源期刊 |
DOI |
Research Field |
Times Cited |
|
1 |
DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE |
NEW ENGLAND JOURNAL OF MEDICINE 383 (15): 1436-1446 OCT 8 2020 |
10.1056/NEJMoa2024816 |
CLINICAL MEDICINE |
851 |
|
2 |
STRUCTURAL AND FUNCTIONAL PROPERTIES OF SARS-COV-2 SPIKE PROTEIN: POTENTIAL ANTIVIRUS DRUG DEVELOPMENT FOR COVID-19 |
ACTA PHARMACOLOGICA SINICA 41 (9): 1141-1149 SEP 2020 |
10.1038/s41401-020-0485-4 |
PHARMACOLOGY & TOXICOLOGY |
563 |
|
3 |
DEVELOPMENT AND VALIDATION OF A CLINICAL RISK SCORE TO PREDICT THE OCCURRENCE OF CRITICAL ILLNESS IN HOSPITALIZED PATIENTS WITH COVID-19 |
JAMA INTERNAL MEDICINE 180 (8): 1081-1089 AUG 2020 |
10.1001/jamainternmed.2020.2033 |
CLINICAL MEDICINE |
547 |
|
4 |
EFFECTS OF DAPAGLIFLOZIN ON MAJOR ADVERSE KIDNEY AND CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETIC AND NON-DIABETIC CHRONIC KIDNEY DISEASE: A PRESPECIFIED ANALYSIS FROM THE DAPA-CKD TRIAL |
LANCET DIABETES & ENDOCRINOLOGY 9 (1): 22-31 JAN 2021 |
0 |
CLINICAL MEDICINE |
99 |
|
5 |
SARS-COV-2 N PROTEIN PROMOTES NLRP3 INFLAMMASOME ACTIVATION TO INDUCE HYPERINFLAMMATION |
NATURE COMMUNICATIONS 12 (1): - AUG 2 2021 |
10.1038/s41467-021-25015-6 |
IMMUNOLOGY |
70 |
|
6 |
SINTILIMAB PLUS A BEVACIZUMAB BIOSIMILAR (IBI305) VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA (ORIENT-32): A RANDOMISED, OPEN-LABEL, PHASE 2-3 STUDY |
LANCET ONCOLOGY 22 (7): 977-990 JUL 2021 |
10.1016/S1470-2045(21)00252-7 |
CLINICAL MEDICINE |
68 |
|
7 |
CALORIE RESTRICTION WITH OR WITHOUT TIME-RESTRICTED EATING IN WEIGHT LOSS |
NEW ENGLAND JOURNAL OF MEDICINE 386 (16): 1495-1504 APR 21 2022 |
10.1056/NEJMoa2114833 |
CLINICAL MEDICINE |
8 |
